Schulz, M.S.; Wolf, S.; Struck, V.; Thomas, N.; Husman, G.; Zeuzem, S.; Koch, C.; Trojan, J.; Schnitzbauer, A.A.; Bechstein, W.O.;
et al. Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis. Cancers 2022, 14, 1641.
https://doi.org/10.3390/cancers14071641
AMA Style
Schulz MS, Wolf S, Struck V, Thomas N, Husman G, Zeuzem S, Koch C, Trojan J, Schnitzbauer AA, Bechstein WO,
et al. Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis. Cancers. 2022; 14(7):1641.
https://doi.org/10.3390/cancers14071641
Chicago/Turabian Style
Schulz, Martin S., Sebastian Wolf, Vera Struck, Niklas Thomas, Gabriele Husman, Stefan Zeuzem, Christine Koch, Jörg Trojan, Andreas Anton Schnitzbauer, Wolf Otto Bechstein,
and et al. 2022. "Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis" Cancers 14, no. 7: 1641.
https://doi.org/10.3390/cancers14071641
APA Style
Schulz, M. S., Wolf, S., Struck, V., Thomas, N., Husman, G., Zeuzem, S., Koch, C., Trojan, J., Schnitzbauer, A. A., Bechstein, W. O., & Waidmann, O.
(2022). Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis. Cancers, 14(7), 1641.
https://doi.org/10.3390/cancers14071641